Vasculitis: Microscopic Polyangiitis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Microscopic polyangiitis (MPA) is a rare disease of unknown etiology. It is characterized by necrotizing inflammation of small blood vessels (arterioles, capillaries, and venules) in the absence of immune deposits and granulomatous inflammation. Antibodies against the content of azurophilic granules in neutrophilic granulocytes (antineutrophil cytoplasmic antibodies (ANCA)), most commonly targeting myeloperoxidase (MPO-ANCA), are present in the majority of patients. Although the etiology of MPA remains unknown, clinical observations and animal models suggest a causal association with MPO-ANCA. Clinically, MPA commonly presents with systemic symptoms, palpable purpura, renal dysfunction, pulmonary hemorrhage, and mononeuritis multiplex. If larger arteries are involved, patients may display disease manifestations historically attributed to panarteritis nodosa. Rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage represent the most frequent life-threatening complications. The combination of glucocorticoids and cyclophosphamide is typically used for remission induction therapy. Despite aggressive therapy, relapses occur commonly and treatment-associated morbidity and mortality are frequently encountered.

Original languageEnglish (US)
Title of host publicationEncyclopedia of Respiratory Medicine, Four-Volume Set
PublisherElsevier Inc.
Pages422-428
Number of pages7
ISBN (Print)9780123708793
DOIs
StatePublished - Jan 1 2006

Fingerprint

Microscopic Polyangiitis
Antineutrophil Cytoplasmic Antibodies
Vasculitis
Mononeuropathies
Hemorrhage
Inflammation
Remission Induction
Purpura
Venules
Blood vessels
Arterioles
Rare Diseases
Glomerulonephritis
Granulocytes
Cyclophosphamide
Glucocorticoids
Peroxidase
Blood Vessels
Animals
Therapeutics

Keywords

  • ANCA-associated vasculitis
  • Antineutrophil cytoplasmic antibodies (ANCA)
  • Cyclophosphamide
  • Diffuse alveolar hemorrhage
  • Glucocorticoids
  • Leukocytoclastic vasculitis
  • Microscopic polyangiitis
  • Myeloperoxidase
  • Palpable purpura
  • Pauci-immune focal segmental necrotizing glomerulonephritis
  • Pulmonary-renal syndrome

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Specks, U., & Peikert, T. D. (2006). Vasculitis: Microscopic Polyangiitis. In Encyclopedia of Respiratory Medicine, Four-Volume Set (pp. 422-428). Elsevier Inc.. https://doi.org/10.1016/B0-12-370879-6/00423-3

Vasculitis : Microscopic Polyangiitis. / Specks, Ulrich; Peikert, Tobias D.

Encyclopedia of Respiratory Medicine, Four-Volume Set. Elsevier Inc., 2006. p. 422-428.

Research output: Chapter in Book/Report/Conference proceedingChapter

Specks, U & Peikert, TD 2006, Vasculitis: Microscopic Polyangiitis. in Encyclopedia of Respiratory Medicine, Four-Volume Set. Elsevier Inc., pp. 422-428. https://doi.org/10.1016/B0-12-370879-6/00423-3
Specks U, Peikert TD. Vasculitis: Microscopic Polyangiitis. In Encyclopedia of Respiratory Medicine, Four-Volume Set. Elsevier Inc. 2006. p. 422-428 https://doi.org/10.1016/B0-12-370879-6/00423-3
Specks, Ulrich ; Peikert, Tobias D. / Vasculitis : Microscopic Polyangiitis. Encyclopedia of Respiratory Medicine, Four-Volume Set. Elsevier Inc., 2006. pp. 422-428
@inbook{fe9696ffde0545beac4cfc61b174daee,
title = "Vasculitis: Microscopic Polyangiitis",
abstract = "Microscopic polyangiitis (MPA) is a rare disease of unknown etiology. It is characterized by necrotizing inflammation of small blood vessels (arterioles, capillaries, and venules) in the absence of immune deposits and granulomatous inflammation. Antibodies against the content of azurophilic granules in neutrophilic granulocytes (antineutrophil cytoplasmic antibodies (ANCA)), most commonly targeting myeloperoxidase (MPO-ANCA), are present in the majority of patients. Although the etiology of MPA remains unknown, clinical observations and animal models suggest a causal association with MPO-ANCA. Clinically, MPA commonly presents with systemic symptoms, palpable purpura, renal dysfunction, pulmonary hemorrhage, and mononeuritis multiplex. If larger arteries are involved, patients may display disease manifestations historically attributed to panarteritis nodosa. Rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage represent the most frequent life-threatening complications. The combination of glucocorticoids and cyclophosphamide is typically used for remission induction therapy. Despite aggressive therapy, relapses occur commonly and treatment-associated morbidity and mortality are frequently encountered.",
keywords = "ANCA-associated vasculitis, Antineutrophil cytoplasmic antibodies (ANCA), Cyclophosphamide, Diffuse alveolar hemorrhage, Glucocorticoids, Leukocytoclastic vasculitis, Microscopic polyangiitis, Myeloperoxidase, Palpable purpura, Pauci-immune focal segmental necrotizing glomerulonephritis, Pulmonary-renal syndrome",
author = "Ulrich Specks and Peikert, {Tobias D}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/B0-12-370879-6/00423-3",
language = "English (US)",
isbn = "9780123708793",
pages = "422--428",
booktitle = "Encyclopedia of Respiratory Medicine, Four-Volume Set",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Vasculitis

T2 - Microscopic Polyangiitis

AU - Specks, Ulrich

AU - Peikert, Tobias D

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Microscopic polyangiitis (MPA) is a rare disease of unknown etiology. It is characterized by necrotizing inflammation of small blood vessels (arterioles, capillaries, and venules) in the absence of immune deposits and granulomatous inflammation. Antibodies against the content of azurophilic granules in neutrophilic granulocytes (antineutrophil cytoplasmic antibodies (ANCA)), most commonly targeting myeloperoxidase (MPO-ANCA), are present in the majority of patients. Although the etiology of MPA remains unknown, clinical observations and animal models suggest a causal association with MPO-ANCA. Clinically, MPA commonly presents with systemic symptoms, palpable purpura, renal dysfunction, pulmonary hemorrhage, and mononeuritis multiplex. If larger arteries are involved, patients may display disease manifestations historically attributed to panarteritis nodosa. Rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage represent the most frequent life-threatening complications. The combination of glucocorticoids and cyclophosphamide is typically used for remission induction therapy. Despite aggressive therapy, relapses occur commonly and treatment-associated morbidity and mortality are frequently encountered.

AB - Microscopic polyangiitis (MPA) is a rare disease of unknown etiology. It is characterized by necrotizing inflammation of small blood vessels (arterioles, capillaries, and venules) in the absence of immune deposits and granulomatous inflammation. Antibodies against the content of azurophilic granules in neutrophilic granulocytes (antineutrophil cytoplasmic antibodies (ANCA)), most commonly targeting myeloperoxidase (MPO-ANCA), are present in the majority of patients. Although the etiology of MPA remains unknown, clinical observations and animal models suggest a causal association with MPO-ANCA. Clinically, MPA commonly presents with systemic symptoms, palpable purpura, renal dysfunction, pulmonary hemorrhage, and mononeuritis multiplex. If larger arteries are involved, patients may display disease manifestations historically attributed to panarteritis nodosa. Rapidly progressive glomerulonephritis and diffuse alveolar hemorrhage represent the most frequent life-threatening complications. The combination of glucocorticoids and cyclophosphamide is typically used for remission induction therapy. Despite aggressive therapy, relapses occur commonly and treatment-associated morbidity and mortality are frequently encountered.

KW - ANCA-associated vasculitis

KW - Antineutrophil cytoplasmic antibodies (ANCA)

KW - Cyclophosphamide

KW - Diffuse alveolar hemorrhage

KW - Glucocorticoids

KW - Leukocytoclastic vasculitis

KW - Microscopic polyangiitis

KW - Myeloperoxidase

KW - Palpable purpura

KW - Pauci-immune focal segmental necrotizing glomerulonephritis

KW - Pulmonary-renal syndrome

UR - http://www.scopus.com/inward/record.url?scp=85069293238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069293238&partnerID=8YFLogxK

U2 - 10.1016/B0-12-370879-6/00423-3

DO - 10.1016/B0-12-370879-6/00423-3

M3 - Chapter

AN - SCOPUS:85069293238

SN - 9780123708793

SP - 422

EP - 428

BT - Encyclopedia of Respiratory Medicine, Four-Volume Set

PB - Elsevier Inc.

ER -